Publications by authors named "Hida T"

Background And Objective: As the most common cancer to progress to brain metastases (BMs), lung cancer presents with intracranial involvement in approximately 20% of patients at the time of diagnosis and lung cancer BMs constitute approximately half of all BMs. The current clinical strategy for managing lung cancer BMs involves a combination of systemic anticancer therapies with local radiation or surgical interventions. The efficacy of systemic treatments is often constrained by the blood-brain barrier (BBB) and the poor inhibition effect of the drug itself.

View Article and Find Full Text PDF

Chemoradiotherapy (CRT) followed by durvalumab is standard for unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study assesses how CRT alters the T-cell receptor (TCR) repertoire in CD8 + PD-1 + T-cells and its impact on clinical outcomes. This prospective study, conducted from November 2019 to May 2021 at three institutions in Japan, evaluated the diversity of TCR repertoire (DE50) in PD-1 + CD8 + T-cells and CD8 + T-cell phenotypes in peripheral blood before and after CRT.

View Article and Find Full Text PDF

Various complications and potential risks of serious adverse events lessens the intensity of chemotherapy in patients with Werner syndrome. Bone marrow carcinomatosis of breast cancer was developed in a patient with Werner syndrome. Eribulin proved well tolerated and effective in improving severe thrombocytopenia, leading to platelet transfusion-free status.

View Article and Find Full Text PDF

Comprehensive studies of the genetic profiles of cutaneous squamous cell carcinoma (cSCC) in Japanese patients have been lacking, although an understanding of these profiles is crucial for improving treatment outcomes. Since 2019, comprehensive genomic profiling (CGP) has been covered by Japan's health insurance, and the resulting data have been compiled into a comprehensive database by the country's Center for Cancer Genomics and Advanced Therapeutics (C-CAT). In this retrospective study, we used CGP data from the C-CAT database to analyze genomic characteristics of cSCC in Japanese patients.

View Article and Find Full Text PDF

Acral lentiginous melanoma (ALM) is the most common melanoma subtype in non-Caucasians. Despite advances in cancer immunotherapy, current immune checkpoint inhibitors remain unsatisfactory for ALM. Hence, we conducted comprehensive immune profiling using single-cell phenotyping with reactivity screening of the T cell receptors of tumor-infiltrating T lymphocytes (TILs) in ALM.

View Article and Find Full Text PDF
Article Synopsis
  • - Acral and mucosal melanomas are more common in Asians compared to Caucasians, while cutaneous melanomas are mainly found in Caucasians; this study focuses on the genetic traits of melanomas in Japanese patients due to under-research in this area.
  • - Analysis of 104 Japanese melanoma samples revealed that 94% had driver mutations, with significant mutations differing among melanoma types: BRAF was notable in cutaneous, while acral exhibited mutations in KIT and others, and mucosal showed various driver mutations like NRAS and KRAS.
  • - The findings suggest a lower tumor mutational burden in East Asian cutaneous melanoma, potentially impacting the effectiveness of immune checkpoint inhibitors and emphasizing the necessity for personalized treatment strategies based on
View Article and Find Full Text PDF

Extramammary Paget's disease (EMPD) is a rare skin cancer with no standard treatment for advanced-stage disease. Although docetaxel-based chemotherapy is common, no standard treatment exists. Pembrolizumab is approved for solid tumors with a high tumor mutation burden (TMB) and/or high microsatellite instability, and nivolumab was approved in Japan in February 2024 for unresectable advanced or recurrent epithelial skin malignancies.

View Article and Find Full Text PDF
Article Synopsis
  • Familial progressive hyperpigmentation with or without hypopigmentation (FPHH) is an autosomal dominant skin disorder caused by mutations in the KITLG gene, leading to widespread hyperpigmentation and distinct skin lesions.
  • A unique case study identified a new KITLG mutation (Ser78Leu) in a patient, revealing multiple hypopigmented macules and striae that follow specific skin patterns.
  • Genetic analysis suggested that these hypopigmented areas may arise from revertant mosaicism, contrasting with café-au-lait spots, which have a different formation process.
View Article and Find Full Text PDF
Article Synopsis
  • This study examines the differences in melanoma types (cutaneous, acral, mucosal, and uveal) and their genetic profiles among Japanese patients, highlighting the prevalence of acral and mucosal melanoma, which are often resistant to standard therapies.
  • A total of 380 melanoma cases were analyzed, revealing that the tumor mutational burden (TMB) across different melanoma types was similar, with key driver mutations identified in each type showing genetic variations specific to their classifications.
  • The research concludes that the unique genomic characteristics and lower TMB in Japanese patients indicate poorer treatment outcomes, emphasizing the urgent need for more effective therapies tailored to this population.
View Article and Find Full Text PDF
Article Synopsis
  • Multiple hereditary infundibulocystic basal cell carcinoma syndrome (MHIBCC) is a genetic disorder linked to SUFU gene mutations, resulting in skin tumors called infundibulocystic basal cell carcinomas (IBCCs).
  • A case study of a 57-year-old woman revealed a rare form of mosaic MHIBCC, where a specific SUFU mutation was found in both her tumors and blood, albeit at different frequencies.
  • The findings suggest that this mosaicism, along with a loss of heterozygosity on chromosome 10, may lead to a milder presentation of MHIBCC but still carries an increased risk for more severe tumors.
View Article and Find Full Text PDF
Article Synopsis
  • - This study analyzed the effectiveness of combined androgen blockade (CAB) using bicalutamide (Bic-CAB) as a first-line treatment for metastatic hormone-sensitive prostate cancer (mHSPC) in Japan, evaluating patient data from 2007 to 2017.
  • - From 159 patients reviewed, nearly half had prostate-specific antigen (PSA) progression, with a median overall survival of about 72.9 months; a significant number achieved low PSA levels quickly.
  • - The research suggests that patients with low initial PSA and minimal changes had excellent long-term survival rates, indicating that Bic-CAB treatment adjusted based on PSA results could be beneficial for low-risk mHSPC patients.
View Article and Find Full Text PDF
Article Synopsis
  • The JAVELIN Lung 101 trial tested avelumab, an immune checkpoint inhibitor, alongside lorlatinib or crizotinib (tyrosine kinase inhibitors) in advanced non-small cell lung cancer (NSCLC).
  • The study aimed to determine the maximum tolerated dose (MTD) and evaluate the treatment's effectiveness based on patient response rates, focusing on dose-limiting toxicities (DLTs).
  • Results showed that avelumab with lorlatinib was manageable with a response rate of 52%, while avelumab with crizotinib was less feasible, with a lower response rate of 25% and high DLT incidence.
View Article and Find Full Text PDF

Background: In cardiac computed tomography (CT), the best image quality is obtained at mid-diastole at low heart rates (HRs) and at end-systole at high HRs. On the other hand, extracellular volume (ECV) measurements may be influenced by the cardiac phase. Therefore, we aimed to clarify the influence of the cardiac phase on the image quality and ECV values obtained using dual-layer spectral computed tomography (DLCT).

View Article and Find Full Text PDF

Background: The occurrence of pulmonary adenocarcinoma coexisting with atypical carcinoid tumors is a rare phenomenon. The presence of fusion in an atypical carcinoid component of a histologically mixed tumor is even more uncommon. Due to their infrequency, the origin and pathogenesis of these mixed tumors remain largely unknown.

View Article and Find Full Text PDF

Introduction: Paratesticular cellular angiofibroma is a rare benign mesenchymal tumor. The optimal management is surgical resection due to the difficulty of preoperative accurate diagnosis.

Case Presentation: A 51-year-old Japanese male visited our hospital complaining of asymptomatic left scrotal swelling.

View Article and Find Full Text PDF

Epidermal keratinocytes, forming the outermost layer of the human body, serve as a crucial barrier against diverse external stressors such as ultraviolet radiation. Proper keratinocyte differentiation and effective responses to external stimuli are pivotal for maintaining barrier integrity. Heat is one such stimulus that triggers the synthesis of heat shock proteins (HSPs) when cells are exposed to temperatures above 42 °C.

View Article and Find Full Text PDF

Background: Immune-related adverse effects (irAEs) often occur during immune checkpoint inhibitor (ICI) therapy. In the nervous system, the incidence of irAEs ranges from 0.1-12%, with 80% occurring within the first 4 months of ICI application.

View Article and Find Full Text PDF

Background: Homeobox ) family genes have been identified as regulators of cancer development. No research exists concerning the mechanisms underlying homeobox B8 () activity in non-small cell lung cancer (NSCLC). In this study, we investigated expression and biological function in NSCLC to determine whether it is an important marker of patient prognosis.

View Article and Find Full Text PDF

To study the inhibitory effects on microphthalmia-associated transcription factor (MITF)-related biological aspects in malignant melanomas (MMs) in the presence or absence of the low-molecular MITF specific inhibitor ML329, cell viability, cellular metabolic functions, and three-dimensional (3D) spheroid formation efficacy were compared among MM cell lines including SK-mel-24, A375, dabrafenib- and trametinib-resistant A375 (A375DT), and WM266-4. Upon exposure to 2 or 10 μM of ML329, cell viability was significantly decreased in WM266-4, SK-mel-24, and A375DT cells, but not A375 cells, in a dose-dependent manner, and these toxic effects of ML329 were most evident in WM266-4 cells. Extracellular flux assays conducted using a Seahorse bioanalyzer revealed that treatment with ML329 increased basal respiration, ATP-linked respiration, proton leakage, and non-mitochondrial respiration in WM266-4 cells and decreased glycolytic function in SK-mel-24 cells, whereas there were no marked effects of ML329 on A375 and A375DT cells.

View Article and Find Full Text PDF